# REVB (Revelation Biosciences, Inc.) - SEC EDGAR Financial Statements

> Revelation Biosciences, Inc. reported $10.02M in total assets and a net loss of $12.16M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/REVB
- Markdown: https://convexityos.com/fundamentals/REVB.md
- SEC CIK: 0001810560
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001810560&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$12.71M | Operating profit |
| Net Income | FY 2025 | -$12.16M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$21.73 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $9.12M | Total debt: $805K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $4.06M | $3.55M | $4.15M | $5.38M | $6.91M | -- | -- |
| Total Operating Expenses | $9.07M | $7.98M | $8.66M | $10.86M | $11.95M | $145K | -- |
| **Operating Income** | -$9.07M | -$7.98M | -$8.66M | -$10.86M | -$11.95M | -- | -- |
| **EBITDA** | -$9.04M | -$7.95M | -$8.63M | -$10.84M | -$11.93M | -- | -- |
| Interest Income | -- | -- | -- | -- | $222 | $9.3K | -- |
| Interest Expense | -- | -- | -- | -- | $42K | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -- | -$136K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -- | -- |
| **Net Income** | -$8.91M | -$15.04M | -$120K | -$10.83M | -$11.99M | -$1.63M | -$3.6K |
| Basic EPS | -$8,050.42 | -$353,667.23 | -$26,197,938.77 | -$50,156,773,540,134.66 | -$181,002,463,926,169,408.00 | -$2,896,039,422,818,710.50 | -- |
| **Diluted EPS** | -$8,050.42 | -$353,667.23 | -$26,197,938.77 | -$50,156,773,540,134.66 | -$181,002,463,926,169,408.00 | -$127,766,445,124,354.88 | -- |
| Basic Shares Outstanding | 1.8K | 43 | 0 | 0 | 0 | 0 | -- |
| Diluted Shares Outstanding | 1.8K | 43 | 0 | 0 | 0 | 0 | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.51M | $1.92M | $1.38M | $964K | $923K | $1.32M | $859K | $606K |
| Total Operating Expenses | $3.38M | $3.66M | $3.09M | $2.57M | $1.94M | $2.46M | $2.09M | $1.75M |
| **Operating Income** | -$3.38M | -$3.66M | -$3.09M | -$2.57M | -$1.94M | -$2.46M | -$2.09M | -$1.75M |
| **EBITDA** | -$3.38M | -$3.65M | -$3.09M | -$2.57M | -$1.94M | -$2.45M | -$2.09M | -$1.75M |
| Income Tax Expense | $0 | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$3.32M | -$3.32M | -$3.01M | -$2.51M | -$1.91M | -$2.44M | -$2.05M | -$1.73M |
| Basic EPS | -$5.92 | -$73.11 | -$910.92 | -- | -$49.51 | -$2,356.30 | -$8,517.65 | -- |
| **Diluted EPS** | -$5.92 | -$73.11 | -$910.92 | -- | -$49.51 | -$2,356.30 | -$8,517.65 | -- |
| Basic Shares Outstanding | 559.6K | 45.6K | 9.5K | -- | 94.5K | 2.4K | 241 | -- |
| Diluted Shares Outstanding | 559.6K | 45.6K | 9.5K | -- | 94.5K | 2.4K | 241 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.70M | $6.50M | $11.99M | $5.25M | $1.27M | $12K | -- |
| Short-Term Investments | -- | -- | -- | -- | -- | $525K | -- |
| **Cash & Short-Term Investments** | $10.70M | $6.50M | $11.99M | $5.25M | $1.27M | $537K | -- |
| **Total Current Assets** | $10.81M | $6.57M | $12.15M | $5.41M | $1.91M | $651K | $23K |
| Property, Plant & Equipment, Net | $18K | $56K | $65K | $90K | $115K | -- | -- |
| Other Non-Current Assets | $31K | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $771K | $56K | $65K | $90K | $130K | $73.51M | $0 |
| **Total Assets** | $11.58M | $6.62M | $12.21M | $5.50M | $2.04M | $74.16M | $23K |
| Accounts Payable | $578K | $784K | $1.36M | $554K | $596K | $34K | -- |
| **Total Current Liabilities** | $2.00M | $1.91M | $5.56M | $4.45M | $2.14M | $3.43M | $26K |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $2.91M | $2.91M | -- |
| **Total Non-Current Liabilities** | $724K | $0 | $0 | $0 | $0 | $2.91M | $0 |
| **Total Liabilities** | $2.72M | $1.91M | $5.56M | $4.45M | $2.14M | $6.34M | $26K |
| **Total Debt (incl. Leases)** | $747K | -- | -- | -- | $17K | -- | -- |
| Common Stock | $226 | $44 | $16 | $77 | $282 | $1.8K | -- |
| Retained Earnings | -$49.42M | -$40.51M | -$25.47M | -$25.35M | -$14.52M | -$5.69M | -$3.6K |
| **Total Stockholders' Equity** | $8.86M | $4.71M | $6.65M | $1.05M | -$99K | $3.41M | -$3.6K |
| Total Equity | $8.86M | $4.71M | $6.65M | $1.05M | -$7.82M | -$5.69M | -$3.6K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.12M | $11.48M | $14.11M | $10.70M | $12.71M | $5.17M | $3.70M | $6.50M |
| **Cash & Short-Term Investments** | $9.12M | $11.48M | $14.11M | $10.70M | $12.71M | $5.17M | $3.70M | $6.50M |
| **Total Current Assets** | $9.27M | $11.68M | $14.21M | $10.81M | $12.83M | $5.36M | $3.93M | $6.57M |
| Property, Plant & Equipment, Net | $164K | $172K | $141K | $18K | $24K | $35K | $42K | $56K |
| Other Non-Current Assets | $31K | $31K | $31K | $31K | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $754K | $813K | $838K | $771K | $24K | $35K | $42K | $56K |
| **Total Assets** | $10.02M | $12.50M | $15.04M | $11.58M | $12.86M | $5.40M | $3.97M | $6.62M |
| Accounts Payable | $1.07M | $931K | $828K | $578K | $1.03M | $829K | $625K | $784K |
| **Total Current Liabilities** | $2.33M | $1.88M | $1.42M | $2.00M | $1.85M | $1.57M | $1.09M | $1.91M |
| **Total Non-Current Liabilities** | $461K | $551K | $638K | $724K | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.79M | $2.43M | $2.06M | $2.72M | $1.85M | $1.57M | $1.09M | $1.91M |
| **Total Debt (incl. Leases)** | $805K | $740K | $759K | $747K | -- | -- | -- | -- |
| Common Stock | $683 | $3.9K | $3.9K | $226 | $3.6K | $1.5K | $964 | $44 |
| Retained Earnings | -$59.07M | -$55.75M | -$52.43M | -$49.42M | -$46.91M | -$45.00M | -$42.56M | -$40.51M |
| **Total Stockholders' Equity** | $7.23M | $10.07M | $12.99M | $8.86M | $11.00M | $3.83M | $2.88M | $4.71M |
| Total Equity | $7.23M | $10.07M | $12.99M | $8.86M | $11.00M | $3.83M | $2.88M | $4.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.91M | -$15.04M | -$120K | -$10.83M | -$2.13M | -$1.63M | -$3.6K |
| Depreciation & Amortization | $27K | $28K | $25K | $25K | $17K | -- | -- |
| Stock-Based Compensation | $595K | $169K | $156K | $301K | $471K | -- | -- |
| Change in Payables | -$206K | -$576K | $750K | -$666K | -$270K | -- | -- |
| **Operating Cash Flow** | -$8.27M | -$18.32M | -$7.29M | -$11.22M | -$11.09M | -$217K | -- |
| Capital Expenditure | -- | -$19K | -- | -- | -$132K | -- | -- |
| **Free Cash Flow** | -- | -$18.34M | -- | -- | -$11.22M | -- | -- |
| Purchases of Investments | -- | -- | -- | -- | -- | -$527K | -- |
| **Investing Cash Flow** | -- | -$19K | -- | -- | -$132K | -$74.04M | -- |
| Common Stock Issued | -- | -- | -- | -- | $600K | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -$35.50M | -- | -- |
| **Financing Cash Flow** | $12.47M | $12.85M | $14.03M | $15.20M | $8.00M | $74.26M | -- |
| **Net Change in Cash** | $4.20M | -$5.49M | $6.74M | $3.98M | -$3.22M | $12K | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.32M | -$3.32M | -$3.01M | -$2.51M | -$1.91M | -$2.44M | -$2.05M | -$1.73M |
| Depreciation & Amortization | $8.2K | $8.3K | $7.2K | $5.9K | $6.8K | $7.2K | $7.2K | $7.2K |
| Stock-Based Compensation | $482K | $401K | $471K | $370K | $874 | $873 | $223K | $73K |
| Change in Payables | $136K | $137K | $217K | -$442K | $191K | $204K | -$159K | -$2.34M |
| **Operating Cash Flow** | -$2.36M | -$2.56M | -$3.21M | -$1.97M | -$1.59M | -$1.92M | -$2.79M | -$3.75M |
| Capital Expenditure | $0 | -$40K | -$72K | -- | -- | -- | -- | $18K |
| **Free Cash Flow** | -$2.36M | -$2.60M | -$3.29M | -- | -- | -- | -- | -$3.73M |
| **Investing Cash Flow** | $0 | -$40K | -$72K | -- | -- | -- | -- | $18K |
| **Financing Cash Flow** | $0 | -$34K | $6.70M | -- | -- | -- | -- | $3.69M |
| **Net Change in Cash** | -$2.36M | -$2.63M | $3.41M | -$2.01M | $7.53M | $1.47M | -$2.79M | -$42K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -100.6% | -319.4% | -1.8% | -1029.0% | -- | -47.8% | -- |
| Return on Assets (ROA) | -77.0% | -227.1% | -1.0% | -196.8% | -587.0% | -2.2% | -16.0% |
| Current Ratio | 5.41x | 3.43x | 2.18x | 1.22x | 0.89x | 0.19x | 0.86x |
| Quick Ratio | 5.36x | 3.40x | 2.15x | 1.18x | 0.60x | 0.16x | -- |
| Debt to Equity | 0.08x | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -168.1% | -106.8% | -76.0% | -100.6% | -73.9% | -221.2% | -500.2% | -319.4% |
| Return on Assets (ROA) | -121.3% | -86.0% | -65.6% | -77.0% | -63.2% | -156.9% | -362.9% | -227.1% |
| Current Ratio | 3.98x | 6.21x | 10.02x | 5.41x | 6.92x | 3.42x | 3.61x | 3.43x |
| Quick Ratio | 3.92x | 6.11x | 9.96x | 5.36x | 6.85x | 3.30x | 3.40x | 3.40x |
| Debt to Equity | 0.11x | 0.07x | 0.06x | 0.08x | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
